Description
A dopamine D2 receptor antagonist (Ki = 0.3 nM in CHO cells expressing the rat receptor); selective for dopamine D2 over D3 receptors (Ki = 9.5 nM); inhibits dipropyl dopamine-induced femoral vasodilation in dogs at 0.5-5 μg/kg; prevents dopamine-induced decreases in pentagastrin-induced gastric antral motility in dogs at 0.5 mg/kg; inhibits apomorphine-induced emesis in dogs (ED50 = 0.031 mg/kg, p.o.); increases serum levels of prolactin in male rats
Formal name: 5-chloro-1-[1-[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)propyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one
Synonyms: KW 5338|NSC 299589
Molecular weight: 425.9
CAS: 57808-66-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Endocrinology & Metabolism|Reproductive Biology||Research Area|Neuroscience|Neuroendocrinology